{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:09:00Z","timestamp":1755216540622,"version":"3.43.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,4]]},"DOI":"10.7759\/cureus.89330","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T13:01:34Z","timestamp":1754312494000},"source":"Crossref","is-referenced-by-count":0,"title":["MRI-Negative Transverse Myelitis Revealing Seropositive Rheumatoid Arthritis in a Young Woman"],"prefix":"10.7759","author":[{"given":"Valentina","family":"Roa Forster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisett","family":"Castellanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2741\/1351","article-title":"Transverse myelitis: pathogenesis, diagnosis and treatment","volume":"9","author":"Krishnan C","year":"2004","unstructured":"Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci. 2004, 9:1483-99. 10.2741\/1351","journal-title":"Front Biosci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03738-5","article-title":"Comparison between MRI-negative and positive results and the predictors for a poor prognosis in patients with idiopathic acute transverse myelitis","volume":"24","author":"Zhou Y","year":"2024","unstructured":"Zhou Y, Chen Q, Gan W, et al.. Comparison between MRI-negative and positive results and the predictors for a poor prognosis in patients with idiopathic acute transverse myelitis. BMC Neurol. 2024, 24:226. 10.1186\/s12883-024-03738-5","journal-title":"BMC Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2008.143","article-title":"Diagnostic workup of patients with acute transverse myelitis: spectrum of clinical presentation, neuroimaging and laboratory findings","volume":"47","author":"Sellner J","year":"2009","unstructured":"Sellner J, L\u00fcthi N, Sch\u00fcpbach WM, et al.. Diagnostic workup of patients with acute transverse myelitis: spectrum of clinical presentation, neuroimaging and laboratory findings. Spinal Cord. 2009, 47:312-7. 10.1038\/sc.2008.143","journal-title":"Spinal Cord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520907900","article-title":"Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies","volume":"27","author":"Sechi E","year":"2021","unstructured":"Sechi E, Krecke KN, Pittock SJ, et al.. Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies. Mult Scler. 2021, 27:303-8. 10.1177\/1352458520907900","journal-title":"Mult Scler"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02837-5","article-title":"Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report","volume":"22","author":"Kolcava J","year":"2022","unstructured":"Kolcava J, Rajdova A, Vlckova E, Stourac P, Bednarik J. Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report. BMC Neurol. 2022, 22:313. 10.1186\/s12883-022-02837-5","journal-title":"BMC Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.142","article-title":"Guillain-Barr\u00e9 syndrome, transverse myelitis and infectious diseases","volume":"15","author":"Rodr\u00edguez Y","year":"2018","unstructured":"Rodr\u00edguez Y, Rojas M, Pacheco Y, et al.. Guillain-Barr\u00e9 syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol. 2018, 15:547-62. 10.1038\/cmi.2017.142","journal-title":"Cell Mol Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910625","article-title":"Blood-Brain barrier disruption in neuroimmunological disease","volume":"25","author":"Shimizu F","year":"2024","unstructured":"Shimizu F, Nakamori M. Blood-Brain barrier disruption in neuroimmunological disease. Int J Mol Sci. 2024, 25:10.3390\/ijms251910625","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/728371","article-title":"Case report of transverse myelitis in a patient receiving etanercept for rheumatoid arthritis","volume":"2013","author":"Defty H","year":"2013","unstructured":"Defty H, Sames E, Doherty T, Hughes R. Case report of transverse myelitis in a patient receiving etanercept for rheumatoid arthritis. Case Rep Rheumatol. 2013, 2013:728371. 10.1155\/2013\/728371","journal-title":"Case Rep Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103131","article-title":"Aquaporins: unexpected actors in autoimmune diseases","volume":"21","author":"Delporte C","year":"2022","unstructured":"Delporte C, Soyfoo M. Aquaporins: unexpected actors in autoimmune diseases. Autoimmun Rev. 2022, 21:103131. 10.1016\/j.autrev.2022.103131","journal-title":"Autoimmun Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.34172\/aim.28804","article-title":"Neuromyelitis in a patient with rheumatoid arthritis: a case report","volume":"27","author":"Qiang F","year":"2024","unstructured":"Qiang F, Li Z, Chen L, Xuan D, Sheng J. Neuromyelitis in a patient with rheumatoid arthritis: a case report. Arch Iran Med. 2024, 27:400-2. 10.34172\/aim.28804","journal-title":"Arch Iran Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200329","article-title":"\"Lupus myelitis\" revisited: a retrospective single-center study of myelitis associated with rheumatologic disease","volume":"12","author":"Krett JD","year":"2025","unstructured":"Krett JD, Filippatou AG, Barreras P, Pardo CA, Gelber AC, Sotirchos ES. \"Lupus myelitis\" revisited: a retrospective single-center study of myelitis associated with rheumatologic disease. Neurol Neuroimmunol Neuroinflamm. 2025, 12:e200329. 10.1212\/NXI.0000000000200329","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.124","article-title":"The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting","volume":"17","author":"Malmstr\u00f6m V","year":"2017","unstructured":"Malmstr\u00f6m V, Catrina AI, Klareskog L. The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol. 2017, 17:60-75. 10.1038\/nri.2016.124","journal-title":"Nat Rev Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24563","article-title":"MRI in transverse myelitis","volume":"40","author":"Goh C","year":"2014","unstructured":"Goh C, Desmond PM, Phal PM. MRI in transverse myelitis. J Magn Reson Imaging. 2014, 40:1267-79. 10.1002\/jmri.24563","journal-title":"J Magn Reson Imaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.971934","article-title":"Case Report: Rheumatoid meningitis with positive NMDAR antibody: a case treated with intravenous immunoglobulin","volume":"13","author":"Zhang H","year":"2022","unstructured":"Zhang H, Wan Y, Mei Z, et al.. Case Report: Rheumatoid meningitis with positive NMDAR antibody: a case treated with intravenous immunoglobulin. Front Immunol. 2022, 13:971934. 10.3389\/fimmu.2022.971934","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2024.12.004","article-title":"Infectious agents in the pathogenesis of autoimmune rheumatic diseases","volume":"276","author":"Korzeniowska A","year":"2025","unstructured":"Korzeniowska A, Bryl E. Infectious agents in the pathogenesis of autoimmune rheumatic diseases. Transl Res. 2025, 276:39-45. 10.1016\/j.trsl.2024.12.004","journal-title":"Transl Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112205","article-title":"Autoantigens as partners in initiation and propagation of autoimmune rheumatic diseases","volume":"34","author":"Rosen A","year":"2016","unstructured":"Rosen A, Casciola-Rosen L. Autoantigens as partners in initiation and propagation of autoimmune rheumatic diseases. Annu Rev Immunol. 2016, 34:395-420. 10.1146\/annurev-immunol-032414-112205","journal-title":"Annu Rev Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.103019","article-title":"Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis","volume":"21","author":"Morales-Ruiz V","year":"2022","unstructured":"Morales-Ruiz V, Ju\u00e1rez-Vaquera VH, Rosetti-Sciutto M, S\u00e1nchez-Mu\u00f1oz F, Adalid-Peralta L. Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis. Autoimmun Rev. 2022, 21:103019. 10.1016\/j.autrev.2021.103019","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007649.pub4","article-title":"Certolizumab pegol (CDP870) for rheumatoid arthritis in adults","volume":"9","author":"Ruiz Garcia V","year":"2017","unstructured":"Ruiz Garcia V, Burls A, Cabello JB, Vela Casasempere P, Bort-Marti S, Bernal JA. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database Syst Rev. 2017, 9:CD007649. 10.1002\/14651858.CD007649.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.3524","article-title":"Risk of inflammatory central nervous system diseases after tumor necrosis factor-inhibitor treatment for autoimmune diseases: a systematic review and meta-analysis","volume":"81","author":"Xie W","year":"2024","unstructured":"Xie W, Sun Y, Zhang W, Zhu N, Xiao S. Risk of inflammatory central nervous system diseases after tumor necrosis factor-inhibitor treatment for autoimmune diseases: a systematic review and meta-analysis. JAMA Neurol. 2024, 81:1284-94. 10.1001\/jamaneurol.2024.3524","journal-title":"JAMA Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/396580-mri-negative-transverse-myelitis-revealing-seropositive-rheumatoid-arthritis-in-a-young-woman","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T13:01:35Z","timestamp":1754312495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/396580-mri-negative-transverse-myelitis-revealing-seropositive-rheumatoid-arthritis-in-a-young-woman"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.89330","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,4]]}}}